Alexander Nowak
Stock Analyst at Lucid Capital
(3.28)
# 2,514
Out of 4,676 analysts
335
Total ratings
41.3%
Success rate
3.1%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMDX Insight Molecular Diagnostics | Initiated Coverage: Buy | $8 | $4.44 | +80.18% | 1 | Aug 24, 2026 | |
| COCH Envoy Medical | Initiated Coverage: Buy | $2 | $0.747 | +167.74% | 1 | Jul 27, 2026 | |
| FOCL EDAP TMS | Initiated Coverage: Buy | $10 | $4.38 | +128.57% | 1 | Jun 22, 2026 | |
| HUT Hut 8 | Maintained: Hold | $12 | $85.50 | n/a | 2 | Apr 1, 2024 | |
| CELC Celcuity | Rated: Buy | n/a | $92.27 | n/a | 16 | Mar 28, 2024 | |
| DMAC DiaMedica Therapeutics | Reiterated: Buy | $8 | $6.74 | n/a | 19 | Mar 20, 2024 | |
| INFU InfuSystem Holdings | Rated: Buy | n/a | $12.02 | n/a | 11 | Mar 15, 2024 | |
| KRMD KORU Medical Systems | Rated: Buy | n/a | $3.21 | n/a | 22 | Mar 14, 2024 | |
| PHAT Phathom Pharmaceuticals | Rated: Buy | n/a | $8.80 | n/a | 2 | Mar 8, 2024 | |
| STXS Stereotaxis | Rated: Buy | n/a | $1.41 | n/a | 11 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $21.58 | n/a | 21 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $50.80 | n/a | 28 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $336.71 | n/a | 27 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $164.92 | n/a | 15 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $2.50 | n/a | 4 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.05 | n/a | 27 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $16.79 | n/a | 17 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.16 | n/a | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 | $72.33 | n/a | 17 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.37 | n/a | 18 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $7.66 | n/a | 1 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.36 | n/a | 8 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $47.02 | n/a | 1 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.34 | n/a | 1 | Jan 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $19.99 | n/a | 1 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $281.72 | n/a | 2 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $479.18 | n/a | 1 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.38 | n/a | 1 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $241.83 | n/a | 1 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.20 | n/a | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $181.69 | n/a | 1 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $4 | $14.08 | n/a | 9 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.32 | n/a | 1 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $23.89 | n/a | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $60 | $1.68 | n/a | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.22 | n/a | 1 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $7.20 | n/a | 9 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $40 | $9.52 | n/a | 10 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $75.92 | n/a | 1 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $43.12 | n/a | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $58 | $37.09 | n/a | 1 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $7.08 | n/a | 2 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $5 | $0.2652 | n/a | 3 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $36 | $0.0001 | n/a | 8 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $211 | $550.01 | n/a | 1 | Feb 1, 2018 |
Insight Molecular Diagnostics
Aug 24, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $4.44
Upside: +80.18%
Envoy Medical
Jul 27, 2026
Initiated Coverage: Buy
Price Target: $2
Current: $0.747
Upside: +167.74%
EDAP TMS
Jun 22, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $4.38
Upside: +128.57%
Hut 8
Apr 1, 2024
Maintained: Hold
Price Target: $12
Current: $85.50
Upside: n/a
Celcuity
Mar 28, 2024
Rated: Buy
Price Target: n/a
Current: $92.27
Upside: n/a
DiaMedica Therapeutics
Mar 20, 2024
Reiterated: Buy
Price Target: $8
Current: $6.74
Upside: n/a
InfuSystem Holdings
Mar 15, 2024
Rated: Buy
Price Target: n/a
Current: $12.02
Upside: n/a
KORU Medical Systems
Mar 14, 2024
Rated: Buy
Price Target: n/a
Current: $3.21
Upside: n/a
Phathom Pharmaceuticals
Mar 8, 2024
Rated: Buy
Price Target: n/a
Current: $8.80
Upside: n/a
Stereotaxis
Mar 5, 2024
Rated: Buy
Price Target: n/a
Current: $1.41
Upside: n/a
Mar 5, 2024
Maintained: Buy
Price Target: n/a
Current: $21.58
Upside: n/a
Feb 29, 2024
Maintained: Hold
Price Target: n/a
Current: $50.80
Upside: n/a
Feb 29, 2024
Rated: Buy
Price Target: n/a
Current: $336.71
Upside: n/a
Feb 23, 2024
Rated: Buy
Price Target: n/a
Current: $164.92
Upside: n/a
Feb 22, 2024
Maintained: Buy
Price Target: $20
Current: $2.50
Upside: n/a
Feb 21, 2024
Downgraded: Hold
Price Target: n/a
Current: $15.05
Upside: n/a
Feb 21, 2024
Rated: Buy
Price Target: n/a
Current: $16.79
Upside: n/a
Feb 15, 2024
Maintained: Hold
Price Target: n/a
Current: $2.16
Upside: n/a
Feb 2, 2024
Rated: Buy
Price Target: $80
Current: $72.33
Upside: n/a
Jan 31, 2024
Rated: Buy
Price Target: n/a
Current: $3.37
Upside: n/a
Jan 29, 2024
Rated: Buy
Price Target: n/a
Current: $7.66
Upside: n/a
Jan 24, 2024
Rated: Buy
Price Target: n/a
Current: $3.36
Upside: n/a
Jan 10, 2024
Maintained: Buy
Price Target: n/a
Current: $47.02
Upside: n/a
Jan 2, 2024
Maintained: Buy
Price Target: n/a
Current: $4.34
Upside: n/a
Nov 2, 2023
Maintained: Buy
Price Target: $40
Current: $19.99
Upside: n/a
Oct 11, 2023
Reiterated: Buy
Price Target: n/a
Current: $281.72
Upside: n/a
Oct 9, 2023
Rated: Buy
Price Target: n/a
Current: $479.18
Upside: n/a
Oct 9, 2023
Maintained: Buy
Price Target: n/a
Current: $4.38
Upside: n/a
Oct 9, 2023
Maintained: Buy
Price Target: n/a
Current: $241.83
Upside: n/a
Oct 3, 2023
Maintained: Buy
Price Target: n/a
Current: $1.20
Upside: n/a
Oct 2, 2023
Rated: Buy
Price Target: n/a
Current: $181.69
Upside: n/a
Jul 24, 2023
Maintained: Hold
Price Target: $2 → $4
Current: $14.08
Upside: n/a
Jul 18, 2023
Maintained: Buy
Price Target: n/a
Current: $11.32
Upside: n/a
Jul 14, 2023
Rated: Buy
Price Target: n/a
Current: $23.89
Upside: n/a
Jul 13, 2023
Rated: Buy
Price Target: $60
Current: $1.68
Upside: n/a
May 26, 2023
Rated: Buy
Price Target: n/a
Current: $3.22
Upside: n/a
May 12, 2023
Rated: Buy
Price Target: $8
Current: $7.20
Upside: n/a
May 9, 2023
Rated: Sell
Price Target: $40
Current: $9.52
Upside: n/a
May 2, 2023
Rated: Buy
Price Target: n/a
Current: $75.92
Upside: n/a
Apr 19, 2023
Reiterated: Buy
Price Target: $28
Current: $43.12
Upside: n/a
Feb 14, 2023
Rated: Buy
Price Target: $58
Current: $37.09
Upside: n/a
Feb 9, 2023
Rated: Buy
Price Target: $3
Current: $7.08
Upside: n/a
May 17, 2022
Maintained: Buy
Price Target: $10 → $5
Current: $0.2652
Upside: n/a
Mar 30, 2022
Maintained: Buy
Price Target: $8 → $36
Current: $0.0001
Upside: n/a
Feb 1, 2018
Maintained: Buy
Price Target: $211
Current: $550.01
Upside: n/a